Cholesterol atheroembolism and combined treatment with steroids and iloprost.

Abstract

Cholesterol atheroembolism (CAE) is a systemic disorder whose incidence has increased in recent decades and that presents high morbidity and mortality. Although several therapeutic alternatives have been reported, there is no consensus about the best treatment for this disease. In this paper we report the case of a patient with CAE with skin, bowel and kidney involvement who presented a good response to combined therapy with steroids and prostaglandin analogues. Although there are no conclusive studies, we recommend this therapeutic alternative in the management of CAE with organic failure.

• Authors: Ángel M Sevillano-Prieto, Eduardo Hernández-Martínez, Jara Caro-Espada, María Molina-Gómez, Eduardo Gutiérrez-Martínez, Enrique Morales-Ruiz, Ester González-Monte, Manuel Praga-Terente
• Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (Nefrologia) Vol. 32 Issue 6 Pg. 824-8 ( 2012) ISSN: 1989-2284 [Electronic] Spain
• PMID: 23169366 (Publication Type: Case Reports, Journal Article)

Chemical References

• Steroids
• Iloprost

Topics

• Aged
• Drug Therapy, Combination
• Embolism, Cholesterol (drug therapy)
• Female
• Humans
• Iloprost (therapeutic use)
• Steroids (therapeutic use)